NeoGenomics
Quarterly Financials
| Values in thousands | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
|---|---|---|---|---|
Revenue | $167,824 | $164,502 | $156,240 | $155,552 |
Gross Profit | 74,880 | 69,042 | 62,017 | 67,588 |
EBITDA | 1,778 | 756 | -7,729 | 4,756 |
EBIT | -16,207 | -17,351 | -25,996 | -13,605 |
Net Income | -17,699 | -18,642 | -27,061 | -14,326 |
Net Change In Cash | 167,824 | 164,502 | 156,240 | 155,552 |
Free Cash Flow | -1,553 | 814 | -31,500 | 10,727 |
Cash | 361,992 | 355,085 | 331,914 | 342,488 |
Basic Shares | 126,953 | 126,405 | 126,111 | 125,929 |
Annual Financials
| Values in thousands | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|
Revenue | $591,643 | $509,728 | $484,329 | $444,448 |
Gross Profit | 244,604 | 187,896 | 187,060 | 185,893 |
EBITDA | -17,607 | -78,631 | 52,075 | 34,852 |
EBIT | -90,190 | -157,836 | -9,993 | -7,037 |
Net Income | -87,968 | -144,250 | -8,347 | 4,172 |
Net Change In Cash | 591,643 | 509,728 | 484,329 | 444,448 |
Cost of Revenue | -53,647 | 66,195 | 77,616 | |
Free Cash Flow | -30,705 | -96,884 | -90,865 | -27,636 |
Cash | 342,488 | 263,180 | 316,827 | 228,713 |
Basic Shares | 125,502 | 124,217 | 119,962 | 111,794 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-09-30 | -$0.13 |
2024-06-30 | $0.03 |
2024-03-31 | -$0.02 |
2023-12-31 | $0.03 |
